Literature DB >> 20031211

Micro-RNA-15a and micro-RNA-16 expression and chromosome 13 deletions in multiple myeloma.

Sophie L Corthals1, Mojca Jongen-Lavrencic, Yvonne de Knegt, Justine K Peeters, H Berna Beverloo, Henk M Lokhorst, Pieter Sonneveld.   

Abstract

We have used copy number variation (CNV) analysis with SNP mapping arrays for miRNA-15a and miRNA-16-1 expression analysis in patients with multiple myeloma (MM) with or without deletion of chromosome 13q14. MiRNA-15a and miRNA-16 display a range of expression patterns in MM patients, independent of the chromosome 13 status. These findings suggest that genes other than miR-15a and miR-16 may explain the prognostic significance of 13q14 deletions. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20031211     DOI： 10.1016/j.leukres.2009.10.026

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


  30 in total

Review 1.  MicroRNA sponges: progress and possibilities.

Authors:  Margaret S Ebert; Phillip A Sharp
Journal:  RNA       Date:  2010-09-20       Impact factor: 4.942

2.  Dysregulation of miRNAs in AL amyloidosis.

Authors:  Liangping Weng; Brian H Spencer; Pamela T SoohHoo; Lawreen H Connors; Carl J O'Hara; David C Seldin
Journal:  Amyloid       Date:  2011-08-11       Impact factor: 7.141

Review 3.  Genomics in multiple myeloma.

Authors:  Nikhil C Munshi; Hervé Avet-Loiseau
Journal:  Clin Cancer Res       Date:  2011-03-15       Impact factor: 12.531

4.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

5.  Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression.

Authors:  Weixin Wang; Meghan Corrigan-Cummins; Emily A Barber; Layla M Saleh; Adriana Zingone; Azam Ghafoor; Rene Costello; Yong Zhang; Roger J Kurlander; Neha Korde; Aldo M Roccaro; Irene M Ghobrial; Ola Landgren; Katherine R Calvo
Journal:  J Mol Diagn       Date:  2015-09-30       Impact factor: 5.568

Review 6.  Role of microRNAs from monoclonal gammopathy of undetermined significance to multiple myeloma.

Authors:  Katherine R Calvo; Ola Landgren; Aldo M Roccaro; Irene M Ghobrial
Journal:  Semin Hematol       Date:  2011-01       Impact factor: 3.851

7.  Role for microRNAs in regulating glucocorticoid response and resistance in multiple myeloma.

Authors:  Michael A Tessel; Ashley L Benham; Nancy L Krett; Steven T Rosen; Preethi H Gunaratne
Journal:  Horm Cancer       Date:  2011-06       Impact factor: 3.869

8.  NF-κB and cancer: a paradigm of Yin-Yang.

Authors:  Gutian Xiao; Jing Fu
Journal:  Am J Cancer Res       Date:  2010-12-06       Impact factor: 6.166

9.  Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements.

Authors:  Francesco Albano; Luisa Anelli; Antonella Zagaria; Nicoletta Coccaro; Paola Casieri; Antonella Russo Rossi; Laura Vicari; Vincenzo Liso; Mariano Rocchi; Giorgina Specchia
Journal:  Mol Cancer       Date:  2010-05-25       Impact factor: 27.401

Review 10.  Versatile roles of extracellular vesicles in cancer.

Authors:  Nobuyoshi Kosaka; Yusuke Yoshioka; Yu Fujita; Takahiro Ochiya
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.